NeurologyLive

Triptans and Cardiovascular Health: What’s Next for Migraine Treatment? The landscape of migraine treatment is constantly evolving. A recent study published in Migraine sheds light on the relationship between triptans, a common medication for migraine relief, and cardiovascular (CV) events. While the research offers reassuring news, it also highlights the need for a nuanced approach … Read more

Obicetrapib and the Future of Alzheimer’s Treatment: A New Dawn? The medical world is buzzing with the potential of obicetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, in the fight against Alzheimer’s disease. Recent findings from the BROADWAY study, presented at the 2025 Alzheimer’s Association International Conference, suggest that this drug could be a game-changer. … Read more

Unveiling the Future: Novel Therapies in the Fight Against Alzheimer’s Disease The relentless pursuit of effective Alzheimer’s disease (AD) treatments continues to captivate the medical and scientific communities. Recent developments, like the PRIMUS-AD study, spotlight the potential of innovative approaches beyond traditional plaque-clearing antibodies. Let’s dive into these exciting advancements and explore the potential future … Read more

Behavioral Therapy vs. Medication: New Insights on Overactive Bladder in Parkinson’s Disease A recent study published in JAMA Neurology has provided compelling evidence about the effectiveness of behavioral therapy for managing overactive bladder (OAB) symptoms in individuals with Parkinson’s disease (PD). This research suggests that, in some cases, behavioral therapy could be as effective as … Read more

Migraine’s Cognitive Connection: Unpacking the Future of Brain Health As a medical journalist, I’ve spent years tracking the evolving landscape of migraine research. This complex neurological condition is far more than just a headache; it has far-reaching impacts, particularly on cognitive function. A recent study, presented at the American Headache Society (AHS) Annual Meeting, brought … Read more

Huntington’s Disease: Navigating the Future of Treatment and Research As a medical journalist specializing in neurological disorders, I’ve been following the advancements in Huntington’s disease (HD) research with keen interest. It’s a challenging condition, but the progress is undeniably encouraging. This article dives into the landscape of HD treatment, focusing on promising therapies and the … Read more

Unlocking Better Sleep: Daridorexant’s Role in Treating Insomnia and Nocturia Recent studies highlight the effectiveness of Daridorexant, an FDA-approved medication for insomnia, in improving sleep quality and reducing nocturia. A notable placebo-controlled, crossover trial demonstrated Daridorexant’s potential to significantly enhance subjective sleep times and decrease daytime impairments in patients experiencing these overlapping conditions. This breakthrough … Read more

The Promise of TRIM72-Targeted Gene Therapy in ALS Researchers have made groundbreaking strides with SineuGene Therapeutics’ SNUG01, an investigational gene therapy targeting TRIM72, offering new hope to patients with amyotrophic lateral sclerosis (ALS). This innovative approach leverages adeno-associated virus (AAV) vectors to deliver the human TRIM72 gene, focusing on enhancing neuronal membrane repair, reducing oxidative … Read more

The Future of Alzheimer’s Treatment: Insights into Lecanemab As the medical community continues its relentless pursuit of effective Alzheimer’s disease (AD) treatments, recent developments surrounding lecanemab (Leqembi) have garnered significant attention. This promising therapy, already FDA-approved, has shown potential in clinical trials that could change the future of AD management. However, experts caution that more … Read more